Salvage prostatic fossa radiation therapy for biochemical failure after radical prostatectomy: The Sheba experience

Israel Medical Association Journal

Volumn 6, Issue 6, 2004, Pages 329-331

  Kundel, Yulia ^a   Pfeffer, Raphael ^a   Lauffer, Menachem ^a   Ramon, Jacob ^a   Catane, Raphael ^a   Symon, Zvi ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

Adenocarcinoma; Prostate specific antigen; Prostatic fossa radiation; Radical prostatectomy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BIOCHEMISTRY; BONE METASTASIS; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CHI SQUARE TEST; EXPERIENCE; FOLLOW UP; GASTROINTESTINAL DISEASE; HUMAN; ISRAEL; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MEDICAL RECORD; PROCTITIS; PROSTATE ADENOCARCINOMA; PROSTATECTOMY; RADIATION DOSE; RECTUM HEMORRHAGE; RETROSPECTIVE STUDY; SAFETY; SALVAGE THERAPY; SCORING SYSTEM; STOMACH CANCER; TREATMENT FAILURE; TREATMENT OUTCOME; URINARY TRACT DISEASE; URINE INCONTINENCE; PATHOLOGY; PROSTATE TUMOR;

HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 3042630618     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Dreicer R. Controversies in the systemic management of patients with evidence of biochemical failure following radical prostatectomy [Review]. Cancer Treat Rev 2002;28(4:189-94.
2. Valicenti RK, Gomella LG, Perez CA. Radiation therapy after radical prostatectomy: a review of the issues and options [Review]. Semin Radiat Oncol 2003;13(2):130-40.
3. Djavan B, Moul JW, Zlotta A, Remzi M, Ravery V. PSA progression following radical prostatectomy and radiation therapy: new standards in the new millenium. Eur Urol 2003;43(1):12-27.
4. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999;281(17):1591-7.
5. Song DY, Thompson TL, Ramakrishnan V, et al. Salvage radiotherapy for rising or persistent PSA after radical prostatectomy. Urology 2002;60(2):281-7.
6. Chawla AK, Thakral HK, Zietman AL, Shipley WU. Salvage radiotherapy after radical prostatectomy for prostate adenocarcinoma: analysis of efficacy and prognostic factors. Urology 2002;59(5):726-31.
7. Grossfeld GD, Chang JJ, Broering JM, et al. Impact of positive surgical margins on prostate cancer recurrence and the use of secondary cancer treatment: data from the CaPSURE database. J Urol 2000;163(4):1171-7.
8. Choo R, Hruby G, Hong J, et al. (IN)-efficacy of salvage radiotherapy for rising PSA or clinically isolated local recurrence after radical prostatectomy. Int J Radiat Oncol Biol Phys 2002;53(2):269-76.
9. Do T, Parker RG, Do C, Tran L, Do L, Dolkar D. Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy. Cancer J Sci Am 1998;4(5):324-30.
10. Roberts SG, Blute ML, Bergstralh EJ, Slezak JM, Zincke H. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer. Mayo Clin Proc 2001;76(6):571-2.
11. Forman JD, Meetze K, Pontes E, et al. Therapeutic irradiation for patients with an elevated post-prostatectomy prostate specific antigen level. J Urol 1997;158(4):1436-9.
12. Katz MS, Zelefsky MJ, Venkatraman ES, Fuks Z, Hummer A, Leibel SA. Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancer. J Clin Oncol 2003; 21(3):483-9.
13. Stephenson AJ, Shariat SF, Kattan MW, et al. Predicting the outcome of salvage radiotherapy for suspected local recurrence of prostate cancer after radical prostatectomy [Abstract]. Proc Am Soc Clin Oncol 2003; 22:392.
14. Harisinghani MG, Barentsz J, Hahn PF, et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 2003;348(25):2491-9.
15. Leventis AK, Shariat SF, Kattan MW, Butler EB, Wheeler TM, Slawin KM. Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy. Clin Oncol. 2001;19(4):1030-9. Erratum in: J Clin Oncol 2001;19(7):2109.
16. Zelefsky MJ, Lyass O, Fuks Z, et al. Predictors of improved outcome for patients with localized prostate cancer treated with neoadjuvant androgen ablation therapy and three-dimensional conformal radiotherapy. J Clin Oncol 1998;16(10):3380-5.
17. Cox JD, Gallagher MJ, Hammond EH, Kaplan RS, Schellhammer PF. Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radiology and Oncology Consensus Panel [Review]. J Clin Oncol 1999;17(4):1155.